Wire Stories
643Rakuten Symphony, Intel and Juniper Networks Introduce Next Generation Distributed RAN and Transport Solution to Further Simplify Open RAN Deployments at Scale
The solution slashes the total cost of ownership and fast-tracks innovations in the radio access network. LOS ANGELES–(BUSINESS WIRE)–Intel Corporation, Juniper Networks,...
- 614
Wellteq Digital Health Inc. Partners With Top Global University to Commercialise Sleep Research
Wellteq Digital Health Inc. (CSE: WTEQ / OTCQB: WTEQF) has signed a Letter of Intent (LOI) to commercialise sleep technology developed by...
- 647
First Patient Dosed in CANbridge Pharmaceuticals CAN008 Phase 2 Trial for Treatment of Glioblastoma Multiforme (GBM) in China
BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals, Inc., a leading China-based global rare disease-focused biopharmaceutical company committed to the research, development, and commercialization...
- 623
Uniphore Announces “Uniphore Unite” Partner Program to Accelerate Global AI and Automation Innovation
New Program Provides Foundation to Support Large-Scale Enterprise Digital Transformation Efforts with Leading Conversational Automation Solutions PALO ALTO, Calif.–(BUSINESS WIRE)–#AI—Uniphore, the leader...
- 672
VideoProc Vlogger Runs Natively on Mac M1, M1 Pro and M1 Max, UP to 300% Performance!
CHENGDU, China–(BUSINESS WIRE)–#applesilicon–Digiarty Software Inc., the industry-leading multimedia software provider has released VideoProc Vlogger in time for the native support of M1...
- 589
VIQ Solutions Announces Commercial Launch of NetScribe™ for Transcription Agencies Across the United Kingdom and Canada
VIQ’s cloud-based transcription workflow automation solutions, powered by Artificial Intelligence, enable efficiency and productivity gains globally PHOENIX, Ariz.–(BUSINESS WIRE)–VIQ Solutions Inc. (“VIQ”,...
- 582
SciNeuro Pharmaceuticals and Mabylon AG to Collaborate on Development of Novel Therapeutics for Neurological Diseases
SHANGHAI & ROCKVILLE, Md. & ZURICH–(BUSINESS WIRE)–SciNeuro Pharmaceuticals, a leader in the discovery and development of innovative therapeutics for the treatment of...
- 644
Kyriba’s Currency Impact Report Reveals $27.87 Billion in Total FX Volatility in Earnings for North American and European Multinational Corporations
The October 2021 Report Shows Persistent FX Vulnerability for North American Corporations Reporting $22.93 Billion in Q2 Tailwinds SAN DIEGO–(BUSINESS WIRE)–Kyriba’s Currency...
- 631
X-IDEA Launches a Fuel Cell Concept Motorcycle – XCELL with Variable Riding Position
SHANGHAI–(BUSINESS WIRE)–At the 19th China International Motorcycle Exhibition in Chongqing , September 17, 2021 , X-IDEA Industry Design Group revealed a fuel...
- 677
Solasia and Nippon Kayaku Announce License Agreement in Japan for New Drug Candidate DARINAPARSIN (SP-02)
TOKYO–(BUSINESS WIRE)–Solasia Pharma K.K. (TOKYO: 4597, Headquarters: Tokyo, Japan, President & CEO: Yoshihiro Arai, hereinafter “Solasia”) and Nippon Kayaku Co., Ltd. (TOKYO:...
